Concepedia

Publication | Open Access

An Adjuvanted, Low‐Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross‐Reactive Immune Responses in Healthy Adults

117

Citations

18

References

2008

Year

Abstract

ClinicalTrials.gov identifier: NCT00457509 .

References

YearCitations

Page 1